Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CATOS: Cromoglycate Adjunctive Therapy for Schizophrenia
NCT03794076Phase 2Recruiting
- Start
- Apr 2019
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium cromoglycate in schizophrenia, schizoaffective disorder. Started Apr 2019; status: recruiting.
02
Drugs
sodium cromoglycate
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT03794076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03794076.